125 related articles for article (PubMed ID: 24393866)
1. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
[TBL] [Abstract][Full Text] [Related]
2. [Examination of outcomes after conversion surgery for Stage IVGastric cancer in our hospital].
Hagino S; Kurata T; Makita N; Tsuneda A; Iwata K; Kiriyama M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2293-5. PubMed ID: 25731500
[TBL] [Abstract][Full Text] [Related]
3. [Conversion therapy of stage IV gastric cancer].
Tanizawa Y; Terashima M; Tokunaga M; Bando E; Kawamura T; Sugisawa N; Miki Y; Makuuchi R; Yamakawa Y; Kinugasa Y; Kanemoto H; Uesaka K; Yasui H
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2469-73. PubMed ID: 23235167
[TBL] [Abstract][Full Text] [Related]
4. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
5. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
6. Significance of surgical treatment in multimodal therapy for stage IV highly advanced gastric cancer.
Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
Hepatogastroenterology; 2013; 60(122):377-81. PubMed ID: 22975650
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
8. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
9. [The Implications of Conversion Surgery for Stage Ⅳ Gastric Cancer].
Uraoka M; Higashida M; Ueno M; Mineta S; Okamoto Y; Kubota H; Watanabe Y; Okada T; Tsuruta A; Fujiwara Y; Ueno T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1797-1799. PubMed ID: 30692357
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases.
Han DS; Suh YS; Kong SH; Lee HJ; Im SA; Bang YJ; Kim WH; Yang HK
J Surg Oncol; 2013 Apr; 107(5):511-6. PubMed ID: 23090791
[TBL] [Abstract][Full Text] [Related]
11. Surgery after preoperative chemotherapy for patients with unresectable advanced gastric cancer.
Yamamoto M; Sakaguchi Y; Matsuyama A; Yoshinaga K; Tsutsui S; Ishida T
Oncology; 2013; 85(4):241-7. PubMed ID: 24107642
[TBL] [Abstract][Full Text] [Related]
12. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
[TBL] [Abstract][Full Text] [Related]
13. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
14. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
[TBL] [Abstract][Full Text] [Related]
17. Survival of gastric cancer with concomitant liver metastases.
Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
[TBL] [Abstract][Full Text] [Related]
18. [Stomach cancer: 10 years experiences with surgical treatment and possibilities for improving the prognosis].
Spataro V; Genoni M; Maurer C; Müller W
Helv Chir Acta; 1993 Mar; 59(4):589-95. PubMed ID: 8473176
[TBL] [Abstract][Full Text] [Related]
19. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis of Conversion Gastrectomy Cases for Stage IV Gastric Cancer].
Ohnishi T; Kinami S; Fujii Y; Miura S; Fujita J; Kaida D; Tomita Y; Fujita H; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1799-1801. PubMed ID: 29394780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
